Re-inventing tumor targeting

Best-in-class, TSL-based tumor targeting.

Explore the science behind Thermosome’s tumor targeting

Setting a new standard for the treatment of locally advanced soft tissue sarcoma.

Explore Thermosome’s pipeline

Experienced team of biotech entrepreneurs.

Get to know Thermosome’s team

First clinical data presented at CTOS 2024 Annual Meeting.

Download pdf

Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.

Latest news

Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate

more news

ESMO Congress 2025

October 17-21, 2025
Berlin, Germany

more Events